baber/WOPTO huggingface dataset:
Patent DE-69333002-D1 (DE)
Inventor: INUI TOSHIHARU
IPC: B41J19/14
Filed: 1993-10-29
Granted: 2003-07-03
Abstract: A recording head having an ejection portion group for ejecting a black ink, and ejection portion groups for ejecting color inks is used. When a black image to be printed by the black ink is present adjacent to a color image to be printed by the color ink, a black image portion adjacent to the color image and a black image portion which is not adjacent to the color image are formed in different scans, thereby obtaining a high-quality image from which ink blurring at a boundary portion between the black and color images is eliminated. <IMAGE>
Patent DE-69333484-D1 (DE)
Inventor: HARDMAN NORMAN
IPC: C07K16/00
Filed: 1993-09-15
Granted: 2004-05-19
Abstract: The invention relates to reshaped human monoclonal antibodies directed against isotypic determinants of immunoglobulin E (IgE), direct equivalents and derivatives of said antibodies. The molecules of the invention are useful for diagnostics, prophylaxis and treatment of allergy.
Patent DE-69402373-D1 (DE)
Inventor: FAURIOT JACQUES
IPC: E05F1/12
Filed: 1994-06-15
Granted: 1997-05-07
Abstract: This is an articulated assembly including two components in engagement with one another via at least one journal (20), with a return spring (22) permanently urging these two components into a relative direction of rest, one with respect to the other. According to the invention, the journal (20) is axially hollowed out and thus forms a housing (28) for the return spring (22), around the border of a notch (29) forming this journal (20) there is provided a lug (30) under which the corresponding leg (27) of the return spring (20) can be engaged and, in which with this notch (29) the component including the bowl with which the journal (20) interacts also includes a recess which intersects this bowl and in which this leg (27) of the return spring (22) may axially engage. Application in particular to electrical apparatus casings in which a flap is articulated to a cover for protecting the electrical apparatus in question, at rest. <IMAGE>
Patent DE-69422795-D1 (DE)
Inventor: CABRI WALTER
IPC: C07D/
Filed: 1994-09-15
Granted: 2000-03-02
Abstract: A process for preparing the 9-amino camptothecin of formula (I) <CHEM>  said process comprising:     (1) reacting a compound of formula (III) <CHEM> wherein the hydroxy group on ring A is in the 10- or 12-position, with a nitrating agent, so obtaining a corresponding compound of formula (IV) <CHEM>   (2) converting the compound of formula (IV) into a corresponding compound of formula (V) <CHEM>  wherein XO is a group that can be removed reductively; and (3) reductively removing the said XO group and reducing the nitro group of the compound of formula (V), so obtaining the 9-amino camptothecin of formula (I), a known antitumor compound.   The present invention includes also in its scope compounds having the above reported formula (V) and compound of formula (VII) <CHEM> which are endowed with antitumor activity.p
Patent DE-69427313-D1 (DE)
Inventor: KRAMLING DR
IPC: B60S1/02
Filed: 1994-01-26
Granted: 2001-07-05
Abstract: A window (glazing) (1) provided with a transparent resistive layer is equipped with a plurality of electrodes (5-7, 13-19) for carrying electric current to the resistive layer. Amongst these electrodes (5-7, 13-19), various pairs of electrodes forming a chronological succession are electrically energised in a recurrent cycle. The power supplied to the individual electrode pairs is selected as a function of the layer resistivity assigned to the electrode pair in question. The invention allows uniform heating of windows with irregular geometry. <IMAGE>
Patent DE-69432513-D1 (DE)
Inventor: LIVINGSTON PHILIP O
IPC: A61K47/48
Filed: 1994-01-21
Granted: 2003-05-22
Abstract: This invention provides a vaccine for stimulating or enhancing the production of an antibody which recognizes a ganglioside in a subject to which the vaccine is administered. The vaccine is comprised of an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject. The vaccine is further comprised of an adjuvant and a pharmaceutically acceptable vehicle. The invention also provides a method of using the vaccine for treating or preventing cancer wherein gangliosides are on the surface or in the stroma of the cancer cells.This invention provides a vaccine for stimulating or enhancing the production of an antibody which recognizes a ganglioside in a subject to which the vaccine is administered. The vaccine is comprised of an amount of ganglioside or oligosaccharide portion thereof conjugated to an immunogenic protein effective to stimulate or enhance antibody production in the subject. The vaccine is further comprised of an adjuvant and a pharmaceutically acceptable vehicle. The invention also provides a method of using the vaccine for treating or preventing cancer wherein gangliosides are on the surface or in the stroma of the cancer cells.
Patent DE-69500887-D1 (DE)
Inventor: LIBORIUS ERIK
IPC: B01J2/16
Filed: 1995-03-07
Granted: 1997-11-20
Abstract: A process for continuously producing coated particles, and in particular, particles in which the coating is uniform, contiguous and of minimal thickness is described, together with an apparatus for conducting the coating process in which a plurality of coating cells connected in series are provided wherein the particles are pneumatically conveyed during the coating application and in which controlled recirculation of particles occurs within each cell and a controlled spray is applied to the particles in order to produce a substantially uniform distribution of coating.
Patent DE-69509628-D1 (DE)
Inventor: KINSTLER OLAF B
IPC: A61K47/48
Filed: 1995-02-08
Granted: 1999-06-17
Abstract: Provided herein are methods and compositions relating to the attachment of water soluble polymers to proteins. Provided are novel methods for N-terminally modifying proteins or analogs thereof, and resultant compositions, including novel N-terminally chemically modified G-CSF compositions and related methods of preparation. Also provided is chemically modified consensus interferon.
Patent DE-69518395-D1 (DE)
Inventor: EDERYD STEFAN
IPC: C04B35/56
Filed: 1995-12-12
Granted: 2000-09-21
Abstract: A corrosion resistant material contains essentially WC, and 0.1 to 10 weight-%, preferably 0,5 to 5 weight-%, of one or more of the metallic carbides TiC, VC, NbC, TaC, Cr3C2, ZrC or combinations thereof or with WC, and either spherical graphite and/or spherical hexagonal BN up to 10 volume-% with a size of about 3  mu m or 1-5 weight-% of one or more of VN, Ti(C,N), CrN, ZrN. In applications with sliding surfaces, it has been found that the material has surprising results regarding low friction characteristics. <IMAGE>
Patent DE-69521901-D1 (DE)
Inventor: DONG LIANG C
IPC: A61K47/34
Filed: 1995-10-20
Granted: 2001-08-30
Abstract: The invention relates to a membrane, which can be injection moulded, comprising polycaprolactone and at least one of a poly (alkylene oxide), poly (ethylene glycol) or poly (hydroxypropylcellulose).
Patent DE-69527802-D1 (DE)
Inventor: HANSEN MARTIN
IPC: C07D277/14
Filed: 1995-12-14
Granted: 2002-09-19
Abstract: The instant invention provides a novel process for preparing benzyl-substituted rhodanine derivatives. The process is particularly useful for synthesizing the enantiomers of such derivatives. Also provided are novel benzyl-substituted mercaptopropanoic acids and benzyl-substituted thiazolidinones. Such compounds are useful for treating inflammatory bowel disease and, accordingly, the present invention provides a method of treating inflammatory bowel disease in mammals utilizing such novel compounds as well as pharmaceutical compositions containing same.
Patent DE-69531461-D1 (DE)
Inventor: COX JAMES L
IPC: A61F/
Filed: 1995-12-28
Granted: 2003-09-11
Abstract: This invention comprises a method of using tubular material (200) to replace a heart valve (118)(120)(162) during cardiac surgery. To create a replacement atrioventricular (mitral or tricuspid) valve (120)(160), the tube inlet is sutured to a valve annulus (121)(162) from which the native leaflets have been removed, and the tube outlet is sutured to papillary muscles (126)(128)(170) in the ventricle (112)(152). To create a semilunar (aortic or pulmonary) valve (118), the tube inlet is sutured to an annulus from which the native cusps have been removed, and the tube is either "tacked" at three points distally inside the artery, or sutured longitudinally along three lines; this allows the flaps of tissue between the three fixation points at the valve outlet to function as movable cusps. These approaches generate flow patterns that closely duplicate the flow patterns of native valves. A preferred tubular material (200) comprises submucosal tissue from the small intestine; this can be taken from the same patient who is undergoing the cardiac operation, to reduce antigenicity. Animal or cadaver intestinal tissue can also be used if properly treated, or a biocompatible synthetic tubular material can be used. This invention also discloses a properly treated intestinal tissue segment or synthetic tubular segment (500) suitable for implantation as a replacement heart valve, enclosed in a sealed sterile package (510). <IMAGE>
Patent DE-69533677-D1 (DE)
Inventor: GELBFISH GARY A
IPC: A61B17/34
Filed: 1995-12-15
Granted: 2004-11-25
Abstract: A method for removing a clot utilizes a surgical instrument or device including an elongate tubular member having a most distal first opening, a relatively central second opening and a most proximal third opening all spaced from each other along the tubular member. The distal end of the tubular member is inserted through a skin surface of a patient into a subcutaneous blood vessel or vascular bypass and subsequently out of the vascular component and the skin surface so that the first opening and the third opening are located outside the patient while the second opening is located in the vascular component. Upon completed insertion of the device, suction is applied to one of the openings outside the patient to thereby draw a blood clot in the blood vessel or vascular bypass towards the second opening which is disposed in the vessel, graft or bypass. Upon a drawing of the clot at least partially into the tubular member through the second opening, a portion of the clot is severed inside the tubular member and is subsequently removed from the tubular member through the suction opening in the tubular member.
Patent DE-69601085-D1 (DE)
Inventor: WHITE PETER
IPC: B29D23/00
Filed: 1996-03-21
Granted: 1999-01-14
Abstract: A method for the manufacture of an electrofusion fitting comprises the following steps:  (i) assembling an electrical heating element 7 and a layer in the form of a mesh tube 13 of thermoplastic polymeric sheet material on a support member which is a collapsible winder mandrel 1; (ii) heating the layer of thermoplastic polymeric sheet material in order to soften the material and cause it to flow in order to form a shape-retaining structure 14 with the electrical heating element 7; and (iii) moulding a body of thermoplastic polymeric material over the structure produced in (ii) and mounted on a collapsible mandrel to form an electrofusion fitting 26.  The structure 14 is removed from the mandrel 1 before the final step of moulding over the structure 14.
Patent DE-69602532-D1 (DE)
Inventor: RASMUSSEN MAX
IPC: B32B7/12
Filed: 1996-07-11
Granted: 1999-06-24
Abstract: PCT No. PCT/DK96/00319 Sec. 371 Date Jan. 13, 1998 Sec. 102(e) Date Jan. 13, 1998 PCT Filed Jul. 11, 1996 PCT Pub. No. WO97/03821 PCT Pub. Date Feb. 6, 1997A laminate is prepared that can be further treated comparatively soon after its preparation, the process comprising that a first solid film is applied with a fluid adhesive layer that cures influenced by a catalyst, whereupon a secondary solid or fluid film consisting totally or partially of plastic material, is brought into contact herewith, whereby the secondary film contains a catalyst for the curing of the adhesive. The laminate prepared is suitable as packaging material, e.g. for food.
Patent DE-69614134-D1 (DE)
Inventor: CHIAVES CARLO
IPC: E04B1/344
Filed: 1996-11-14
Granted: 2001-08-30
Abstract: PCT No. PCT/EP96/04989 Sec. 371 Date May 12, 1998 Sec. 102(e) Date May 12, 1998 PCT Filed Nov. 17, 1996 PCT Pub. No. WO97/19231 PCT Pub. Date May 29, 1997A prefabricated structure for the construction of open air structures, particularly motorway flyovers, underpasses, bridges, tunnels, underground carparks and the like, includes a plurality of prefabricated elements of reinforced concrete. These elements are able to define the side walls and the deck of the work with adjacent longitudinal sections of the structure which rest on a foundation at the base of the work. Each section of the structure includes a pair of side elements which rest on the foundation via a static hinge and are intended to be disposed symmetrically with respect to the axle of the structure so as to assume a substantially L-shaped configuration. A substantially rectilinear prefabricated element is interposed centrally between two side elements and is anchored thereto so as to define a central portion of the deck of the work.
Patent DE-69618496-D1 (DE)
Inventor: GRUBER JAMES VINCENT
IPC: C08B37/00
Filed: 1996-04-09
Granted: 2002-02-21
Abstract: Processes for the preparation of polyglucosamine derivatives, e.g., hydroxypropyl chitosan and carboxymethyl chitosan, are disclosed. The polyglucosamine derivatives can be prepared in a covalently bonded form using a dilute caustic medium or ionically bonded form. Strong bases and undesirable water-immiscible organic solvents can be avoided. The covalently bonded derivatives dissolve into the dilute caustic medium upon formation. Compositions containing the derivatives and uses for the derivatives are also disclosed.
Patent DE-69630704-D1 (DE)
Inventor: HUSTED ROYCE H
IPC: A63B23/04
Filed: 1996-12-13
Granted: 2003-12-18
Abstract: An exercise device that simulates a striding action includes a base. Four linkages support two independently swingable side-by-side foot platforms from spaced apart front and rear supports secured to uprights that are connected to the base. The front and rear supports are positioned with respect to the foot platforms to substantially match the swing length of a person's leg. The distance between the front and rear supports is less than the distance between the front and rear pivots on the foot platforms. Outwardly extending handles are integral with the foot, platforms and are spaced farther apart than the distance between the foot platforms. The rear of each foot platform is slightly elevated with respect to its front.
Patent DE-69633387-D1 (DE)
Inventor: REETZ R
IPC: D04H1/58
Filed: 1996-06-07
Granted: 2004-10-21
Abstract: A method of forming a thermoactive binder composite product is performed by injecting a hot dry gas to activate the thermoactive binder. In the preferred embodiment, the hot dry gas is air. The method is particularly beneficial as applied to forming thermoplastic composite products and particularly thermoplastic/cellulose composites. Also part of the present invention is a two stage pressing process in which hot gas is injected during the first stage and the press charge is precompressed. The press charge is then placed in a second consolidation press where the hot gas is no longer injected and it is consolidated and cooled. Machinery for practicing the method includes a platen with a platen press which includes upper and lower platens with a plurality of hot air injection jets disposed on the surface of each platen. The platens are spaced apart and surrounded on the sides by an air-permeable containment shell structure to form a compression chamber to hold the base material to be pressed. Other machinery includes a consolidation press.
Patent DE-69637123-D1 (DE)
Inventor: GORDON ERLINDA M
IPC: C07K14/47
Filed: 1996-10-31
Granted: 2007-07-19
Abstract: A method of treating a tumor (in particular osteosarcoma or Ewing's sarcoma) in a host by administering to a host or to the tumor cells an agent which inhibits cyclin G1 protein in an amount effective to inhibit cyclin G1 protein in tumor cells of the host. The agent may be an antisense polynucleotide which is complementary to at least a portion of a polynucleotide encoding cyclin G1 protein, or an antibody or fragment or derivative thereof which recognizes cyclin G1 protein. Also contemplated within the scope of the present invention are (i) the immortalization of cell lines by transducing cells with a polynucleotide encoding cyclin G1 protein; (ii) increasing the receptiveness of cells to retroviral infection by transducing cells with a polynucleotide encoding cyclin G1 protein; and (iii) the detection of cancer by detecting cyclin G1 protein or a polynucleotide encoding cyclin G1 protein in cells. In addition, the present invention provides expression vehicles, such as, for example, retroviral vectors and adenoviral vectors, which include polynucleotides which encode agents which inhibit cyclin G1 protein, and expression vehicles which include a polynucleotide encoding cyclin G1 protein.
Patent DE-69707573-D1 (DE)
Inventor: ALARY JEAN-ANDRE
IPC: B24C11/00
Filed: 1997-07-09
Granted: 2001-11-29
Abstract: The surfaces of components made of aluminium or their alloys are treated by sand blasting, using an abrasive powder projected against the surfaces in a jet of compressed air. The powder is prepared by electro-melting a mix of corundum and 20-45% by weight of zirconia.
Patent DE-69708279-D1 (DE)
Inventor: HJELMVIK TORBERNT
IPC: G07B15/02
Filed: 1997-03-21
Granted: 2001-12-20
Abstract: A method of cash card billing with the aid of pay meters when parking a vehicle, using a parking meter system which includes a plurality of meters. The meters include a cash card reader. A person parking a vehicle finds a first meter (BA 1) where the cash card is read and the cash card account (KN) number and the parking commencement time are stored in a memory (BA1 MEM). When terminating the parking period the person finds a second pay meter (BA 2), which stores the card number (KN) together with the perking termination time (UT) in a memory (BA2 MEM). The invention is characterized in that each pay meter includes a keypad (2, 3) by which the person parking the vehicle keys-in the registration number (RN) of the vehicle at the commencement of a parking period in conjunction with reading the cash card, wherein the pay meter stores the registration number (RN) together with the card number (KN) and the parking commencement time (IT); in that the memory (BA1 MEM, BA2 MEM) of each pay meter is connected to the memory of a central computer (7); and in that the cash card account number is billed for the parking period.
Patent DE-69719570-D1 (DE)
Inventor: NEUMANN KARL-ERIK
IPC: B23D79/00
Filed: 1997-07-07
Granted: 2003-04-10
Abstract: A deburrung method, in which a laser (3) is directed towards the edge of a workpiece (1) so that the position of a first surface (5) and a second surface (6) joining the first surface at an angle, can be determined, after which extrapolation of a cutting curve (8) between the first surface (5) and the second surface (6) is performed and in that the burr (2) is removed along the cutting curve (8).
Patent DE-69726797-D1 (DE)
Inventor: DRIESSEN JAN
IPC: B01F7/16
Filed: 1997-07-09
Granted: 2004-01-29
Abstract: A device for mixing dry ingredients for a herb or spice mixture comprises a frame (1,4) equipped with a mixing vessel (2) and a driving motor which, by means of a drive shaft, realises a homogeneous mixing within the mixture. The mixing vessel (2) is placed perpendicular to the drive shaft (3) of the driving motor, so that, during operation, the mixture in it will, time and again, be overturned. For the purpose of a smooth changing of the mixing vessel (2) for another one, the mixing vessel is detachably mounted to the frame (4). Thanks to a similar replacement of mixing vessels, cross-contamination of successive herb mixtures can be minimised, without long cleaning times being required. <IMAGE>
Patent DE-69734765-D1 (DE)
Inventor: WALKER PATRICK MICHAEL CRANSTO
IPC: F16F15/24
Filed: 1997-03-27
Granted: 2006-01-05
Abstract: A crankshaft and piston arrangement for a combustion engine including a piston pivotally connected to a crankshaft by a connecting rod and two balance structures each including a balance structure connecting rod connected to the crankshaft and a balance arm having a longitudinal axis and pivotally connected to the balance structure connecting rod. The balance arm is pivotally connectable at an end remote from the balance structure connecting rod to the engine. The longitudinal axes of the balance arms extend in substantially opposite directions to one another and are substantially perpendicular to a plane through the crankshaft rotational axis (C) and center of the piston when the piston is at substantially mid-stroke and rotate in opposite directions to one another in use. Each balance structure is substantially diametrically opposed to a piston with respect to the crankshaft rotational axis thereby operably to balance forces generated by the acceleration and deceleration of the piston in use. The L/R ratios for the piston connecting rod and the balance structure connecting rod are substantially equal.
Patent DE-69811248-D1 (DE)
Inventor: CATTELIN FRANCOISE
IPC: A61K31/15
Filed: 1998-06-02
Granted: 2003-03-13
Abstract: PCT No. PCT/FR98/01100 Sec. 371 Date Mar. 27, 2000 Sec. 102(e) Date Mar. 27, 2000 PCT Filed Jun. 2, 1998 PCT Pub. No. WO99/00119 PCT Pub. Date Jan. 7, 1999The invention relates to the use of a specific 5HT2 receptor antagonist for the preparation of medicines useful in the treatment of the sleep apnea syndrome.
Patent DE-69815284-D1 (DE)
Inventor: SCHAAD RAYMOND
IPC: A47F7/02
Filed: 1998-03-11
Granted: 2003-07-10
Abstract: The stand (1) consists of a base (2) and a display plate (4) made e.g. from an injected or molded plastic. The base and plate are connected by a hinge (6) which allows the plate to be laid flat on top of the base or set at an angle to it. The hinge comprises a circular recess in the lower end of the plate and a cylinder (34) with a partly grooved surface on the base to engage with the recess. A tongue (42) on the tip of the plate fits into a slot (44) in the base.
Patent DE-69817915-D1 (DE)
Inventor: THOMPSON RICHARD CRAIG
IPC: A61P31/04
Filed: 1998-05-05
Granted: 2003-10-16
Abstract: The present invention is directed to N<LEU>-carbamoyl and thiocarbamoyl derivatives of A82846B and N<DISACC> variations thereof. These derivatives are useful as antibacterials and also as starting materials from which further antibacterial compounds are prepared. <CHEM>
Patent DE-69823361-D1 (DE)
Inventor: GUNASEKARAN SUBRAMANIAN
IPC: C07K1/14
Filed: 1998-01-12
Granted: 2004-05-27
Abstract: Purified collagen is produced by a method containing steps of contacting a collagen sample with a first proteolytic enzyme followed by contacting with a reducing agent and a second proteolytic enzyme. Preferably, the first and second proteolytic enzymes are papain and the reducing agent is sodium sulfide, dithiothreitol, glutathionine or sodium borohydride. A biocompatible collagen is prepared by contacting the purified collagen with a delipidation agent such as chloroform or methanol to produce delipidated collagen, and then contacting the delipidated collagen with a phosphorylation agent such as sodium trimetaphosphate. Prior to phosphorylation, the delipidated collagen may be treated by compressing, dehydrating, dispersing and drying to form collagen fibers. Also, prior to phosphorylation, the delipidated collagen may be treated by filter-sterilizing. De-epithelializing of the collagen may carried out prior to treating with the first proteolytic enzyme. The purified and biocompatible collagen may be used in transplantation or hemostasis, and may be provided with compounds such as antimicrobials, antivirals, growth factors and other compounds suitable for biomedical use.